JAK inhibitors in difficult-to-treat adult-onset Still’s disease and systemic-onset juvenile idiopathic arthritis
Louise Gillard(Sorbonne Université), Stéphane Mitrovic(Sorbonne Université), Fleur Cohen‐Aubart(Inserm), Isabelle Koné‐Paut(Université Paris-Saclay), Gaël Mouterde(Hôpital Lapeyronie), Bruno Fautrel, Alexandre Bélot(Université Claude Bernard Lyon 1), Héloïse Reumaux(Hôpital Jeanne de Flandre), Martin Michaud(Centre Hospitalier Universitaire de Toulouse), Léa Savey(Sorbonne Université), J. Pouchot(Hôpital Européen Georges-Pompidou)
Cited by 63
Related Papers
Proinflammatory Cytokines, Aging, and Age-Related Diseases
|Journal of the American Medical Directors Association|2013|1.1k
Use of Canakinumab in the Cryopyrin-Associated Periodic Syndrome
|New England Journal of Medicine|2009|857
Should we stimulate or suppress immune responses in COVID-19? Cytokine and anti-cytokine interventions
|Autoimmunity Reviews|2020|693